# CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children

> **NCT07023744** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Manitoba** · enrollment: 90 (estimated)

## Conditions studied

- Drug Resistant Epilepsy

## Interventions

- **DRUG:** Placebo
- **DRUG:** CBD Isolate
- **DRUG:** CBD CHE

## Key facts

- **NCT ID:** NCT07023744
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07023744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07023744, "CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07023744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*